These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 29181981)
21. Establishment and maintenance of B cell identity. Grosschedl R Cold Spring Harb Symp Quant Biol; 2013; 78():23-30. PubMed ID: 24733381 [TBL] [Abstract][Full Text] [Related]
22. Defining B Cell Chromatin: Lessons from EBF1. Boller S; Li R; Grosschedl R Trends Genet; 2018 Apr; 34(4):257-269. PubMed ID: 29336845 [TBL] [Abstract][Full Text] [Related]
23. Pioneering Activity of the C-Terminal Domain of EBF1 Shapes the Chromatin Landscape for B Cell Programming. Boller S; Ramamoorthy S; Akbas D; Nechanitzky R; Burger L; Murr R; Schübeler D; Grosschedl R Immunity; 2016 Mar; 44(3):527-541. PubMed ID: 26982363 [TBL] [Abstract][Full Text] [Related]
24. Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia. Iglesias P; Puller AC; Seoane M; Spohn M; Raasch S; Klokow M; Müller J; Burkhardt L; Indenbirken D; Horstmann MA Blood Adv; 2021 Mar; 5(5):1209-1223. PubMed ID: 33646306 [TBL] [Abstract][Full Text] [Related]
25. ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. Mesuraca M; Chiarella E; Scicchitano S; Codispoti B; Giordano M; Nappo G; Bond HM; Morrone G Biomed Res Int; 2015; 2015():165238. PubMed ID: 26788497 [TBL] [Abstract][Full Text] [Related]
26. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex. Bullerwell CE; Robichaud PP; Deprez PML; Joy AP; Wajnberg G; D'Souza D; Chacko S; Fournier S; Crapoulet N; Barnett DA; Lewis SM; Ouellette RJ Sci Rep; 2021 Jan; 11(1):1537. PubMed ID: 33452395 [TBL] [Abstract][Full Text] [Related]
27. Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors. Mega T; Lupia M; Amodio N; Horton SJ; Mesuraca M; Pelaggi D; Agosti V; Grieco M; Chiarella E; Spina R; Moore MA; Schuringa JJ; Bond HM; Morrone G Cell Cycle; 2011 Jul; 10(13):2129-39. PubMed ID: 21593590 [TBL] [Abstract][Full Text] [Related]
28. B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1. Hagman J; Ramírez J; Lukin K Curr Top Microbiol Immunol; 2012; 356():17-38. PubMed ID: 21735360 [TBL] [Abstract][Full Text] [Related]
29. Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming. Li R; Cauchy P; Ramamoorthy S; Boller S; Chavez L; Grosschedl R Genes Dev; 2018 Jan; 32(2):96-111. PubMed ID: 29440261 [TBL] [Abstract][Full Text] [Related]
30. Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia. Wang C; Li L; Li M; Shen X; Liu Y; Wang S Exp Cell Res; 2021 Jan; 398(1):112371. PubMed ID: 33188849 [TBL] [Abstract][Full Text] [Related]
31. [A single miRNA complements transcription factor deficiency through the TGF pathway at time of B-cell lineage determination]. Kotaki R; Kotani A Rinsho Ketsueki; 2017; 58(7):792-797. PubMed ID: 28781276 [TBL] [Abstract][Full Text] [Related]
32. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Decker T; Pasca di Magliano M; McManus S; Sun Q; Bonifer C; Tagoh H; Busslinger M Immunity; 2009 Apr; 30(4):508-20. PubMed ID: 19345119 [TBL] [Abstract][Full Text] [Related]
33. The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program. Itoh-Nakadai A; Hikota R; Muto A; Kometani K; Watanabe-Matsui M; Sato Y; Kobayashi M; Nakamura A; Miura Y; Yano Y; Tashiro S; Sun J; Ikawa T; Ochiai K; Kurosaki T; Igarashi K Nat Immunol; 2014 Dec; 15(12):1171-80. PubMed ID: 25344725 [TBL] [Abstract][Full Text] [Related]
34. A Prion-like Domain in Transcription Factor EBF1 Promotes Phase Separation and Enables B Cell Programming of Progenitor Chromatin. Wang Y; Zolotarev N; Yang CY; Rambold A; Mittler G; Grosschedl R Immunity; 2020 Dec; 53(6):1151-1167.e6. PubMed ID: 33159853 [TBL] [Abstract][Full Text] [Related]
35. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma. Bohle V; Döring C; Hansmann ML; Küppers R Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882 [TBL] [Abstract][Full Text] [Related]
36. Tnpo3 enables EBF1 function in conditions of antagonistic Notch signaling. Bayer M; Boller S; Ramamoothy S; Zolotarev N; Cauchy P; Iwanami N; Mittler G; Boehm T; Grosschedl R Genes Dev; 2022 Aug; 36(15-16):901-915. PubMed ID: 36167471 [TBL] [Abstract][Full Text] [Related]
37. Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression. Lukin K; Fields S; Lopez D; Cherrier M; Ternyak K; Ramírez J; Feeney AJ; Hagman J Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7869-74. PubMed ID: 20385820 [TBL] [Abstract][Full Text] [Related]
38. The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function. Boller S; Grosschedl R Immunol Rev; 2014 Sep; 261(1):102-15. PubMed ID: 25123279 [TBL] [Abstract][Full Text] [Related]
39. Ebf1 in DNA repair and leukemogenesis. Georgopoulos K Blood; 2015 Jun; 125(26):3969-71. PubMed ID: 26113531 [TBL] [Abstract][Full Text] [Related]
40. B cell development is critically dependent on NFATc1 activity. Giampaolo S; Wójcik G; Klein-Hessling S; Serfling E; Patra AK Cell Mol Immunol; 2019 May; 16(5):508-520. PubMed ID: 29907883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]